英科医疗(300677.SZ)：拟参与投资Warburg Pincus Global Growth15, L.P

Core Viewpoint - In order to optimize its investment structure and enhance its global strategic layout, the company has decided to invest in Warburg Pincus Global Growth 15, L.P. through its wholly-owned subsidiary, aiming to improve its revenue levels and long-term strategic development [1] Group 1 - The company held its 11th meeting of the 4th Board of Directors on October 20, 2025, where it approved the proposal to invest in Warburg Pincus Global Growth 15, L.P. [1] - The investment will be made by the company's subsidiary, Inco Medical International (Hong Kong) Limited, which will sign a subscription agreement to invest in the fund [1] - The target fundraising size of the partnership is set at $1.7 billion, with the company committing to contribute $70 million as a limited partner [1]